AI
| Followers | 250 |
| Posts | 14020 |
| Boards Moderated | 3 |
| Alias Born | 07/07/2006 |
Wednesday, August 10, 2011 11:52:36 AM
NSPH 1.40 Annotated chart and insider buys
Buy them when they are oversold , low volume makes for exagerrated lows.
Nanotech company aiming the medical diagnostics sector
"Nanosphere develops, manufactures and markets an advanced molecular diagnostics platform, the Verigene System, that enables simple, low cost and highly sensitive genomic and protein testing on a single platform. Our proprietary nanoparticle technology simplifies the ability to perform molecular diagnostic tests, achieves ultra-sensitive protein detection at limits beyond current diagnostic technologies, provides the ability to multiplex, or run multiple tests at the same time on the same sample"
Committed insider buys here - note the prices they liked to load up on.
Negative divergence on the bottoms for this chart:
(self updating annotated chart)
Buy them when they are oversold , low volume makes for exagerrated lows.
Nanotech company aiming the medical diagnostics sector
"Nanosphere develops, manufactures and markets an advanced molecular diagnostics platform, the Verigene System, that enables simple, low cost and highly sensitive genomic and protein testing on a single platform. Our proprietary nanoparticle technology simplifies the ability to perform molecular diagnostic tests, achieves ultra-sensitive protein detection at limits beyond current diagnostic technologies, provides the ability to multiplex, or run multiple tests at the same time on the same sample"
Committed insider buys here - note the prices they liked to load up on.
Negative divergence on the bottoms for this chart:
(self updating annotated chart)
To follow my postings on ihub use this link : Ihub person mark
Feedback is allways appreciated, as are other (annotated) picks
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
